Clonal haematopoiesis of indeterminate potential‐related mutations and outcome in dilated and ischaemic cardiomyopathy
Abstract Aims Clonal haematopoiesis of indeterminate potential (CHIP)‐associated mutation is a risk factor for the development of ischaemic cardiomyopathy (ICM), but its association with non‐ischaemic dilated cardiomyopathy (DCM) remains unclear. We aimed to determine the prevalence of CHIP in patie...
Main Authors: | Jasmine M.F. Wu, Tarek Bekfani, Anna Hinze, Julian Georg Westphal, Berit Steinacker, Max Zeller, Charlotte Hartmann, Sven Möbius‐Winkler, Andreas Hochhaus, P. Christian Schulze, Thomas Ernst |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14115 |
Similar Items
-
Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
by: Jihye Park, et al.
Published: (2023-03-01) -
Full spectrum of clonal haematopoiesis‐driver mutations in chronic heart failure and their associations with mortality
by: Katharina C. Kiefer, et al.
Published: (2021-06-01) -
Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
by: Shengfang Wang, et al.
Published: (2022-04-01) -
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
by: Veronica Papa, et al.
Published: (2020-08-01) -
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
by: Camilla Bertuzzo Veiga, et al.
Published: (2021-04-01)